Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Nov;11(21):e026097.
doi: 10.1161/JAHA.122.026097. Epub 2022 Oct 26.

Myocarditis After COVID-19 Vaccination in Pediatrics: A Proposed Pathway for Triage and Treatment

Nefthi Sandeep  1   2 , Mary P Fairchok  3 , Keren Hasbani  4   2
Affiliations
Editorial

Myocarditis After COVID-19 Vaccination in Pediatrics: A Proposed Pathway for Triage and Treatment

Nefthi Sandeep et al. J Am Heart Assoc. 2022 Nov.
No abstract available

Keywords: COVID‐19 vaccine; myocarditis; pathway; pediatric.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Pathway for myocarditis after COVID‐19 vaccine.
BID indicates twice a day; BNP, brain natriuretic peptide; CMP, comprehensive metabolic panel; COVID, coronavirus disease; CRP, C‐reactive protein; EBV, Epstein–Barr virus; ED, emergency department; ESR, erythrocyte sedimentation rate; IVIG, intravenous immunoglobulin; LV, left ventricle; LVEF, left ventricular ejection fraction; MIS‐C, multisystem inflammatory syndrome in children; MRI, magnetic resonance imaging; PCR, polymerase chain reaction; and XR, x‐ray.
See this image and copyright information in PMC

Comment in

References

    1. Hause AM, Baggs J, Gee J, Marquez P, Myers TR, Shimabukuro TT, Shay DK. Safety monitoring of an additional dose of COVID‐19 vaccine—United States, August 12‐September 19, 2021. MMWR Morb Mortal Wkly Rep. 2021;70:1379–1384. doi: 10.15585/mmwr.mm7039e4 - DOI - PMC - PubMed
    1. Gargano JW, Wallace M, Hadler SC, Langley G, Su JR, Oster ME, Broder KR, Gee J, Weintraub E, Shimabukuro T, et al. Use of mRNA COVID‐19 vaccine after reports of myocarditis among vaccine recipients: update from the Advisory Committee on Immunization Practices—United States, June 2021. MMWR Morb Mortal Wkly Rep. 2021;70:977–982. doi: 10.15585/mmwr.mm7027e2 - DOI - PMC - PubMed
    1. Oster ME, Shay DK, Su JR, Gee J, Creech CB, Broder KR, Edwards K, Soslow JH, Dendy JM, Schlaudecker E, et al. Myocarditis cases reported after mRNA‐based COVID‐19 vaccination in the US from December 2020 to August 2021. JAMA. 2022;327:331–340. doi: 10.1001/jama.2021.24110 - DOI - PMC - PubMed
    1. Truong DT, Dionne A, Muniz JC, McHugh KE, Portman MA, Lambert LM, Thacker D, Elias MD, Li JS, Toro‐Salazar OH, et al. Clinically suspected myocarditis temporally related to COVID‐19 vaccination in adolescents and young adults. Circulation. 2021;145:345–356. doi: 10.1161/CIRCULATIONAHA.121.056583 - DOI - PubMed
    1. Das BB, Kohli U, Ramachandran P, Nguyen HH, Greil G, Hussain T, Tandon A, Kane C, Avula S, Duru C. Myopericarditis following mRNA COVID‐19 vaccination in adolescents 12 through 18 years of age. J Pediatr. 2021;238:26–32.e1. - PMC - PubMed

Publication types

Substances